Six-year outcomes from the FROST trial show breast cancer cryoablation achieved low ipsilateral recurrence and high invasive ...

The BOOG 2013-08 trial evaluates whether SLNB can be safely omitted for patients with clinically T1-2N0 treated with ...

Lymphatic mapping, a recent technique first developed for the management of melanoma, is based on the concept that information about the status of the entire lymphatic drainage from a tumor site could ...

Omitting SLNB in older patients with early-stage, HR-positive, HER2-negative breast cancer showed similar safety and efficacy to performing the procedure. The BOOG 13-08 trial demonstrated comparable ...

Among patients with early-stage, node-negative breast cancer and one or two sentinel node macrometastases, those who underwent sentinel node biopsy only had noninferior 5-year recurrence-free survival ...

Preoperative axillary ultrasound and MRI effectively predict sentinel lymph node status, guiding safe SLNB de-escalation in ...

Please provide your email address to receive an email when new articles are posted on . Certain groups of women with early-stage breast cancer may not benefit from sentinel lymph node biopsy.

The use of artificial intelligence to detect sentinel lymph nodes in patients with breast cancer may be able to save time and reduce costs as compared with immunohistochemistry. Artificial ...

SLN staging accuracy is independent of the size of metastasis and, therefore, is a highly sensitive method of detecting early-stage, metastatic disease. This sensitivity was emphasized in our study, ...

Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System Lymph node involvement is one of the most important factors influencing recurrence ...